Bandaram Pharma Packtech Ltd. is significantly underperforming compared to its peers in terms of profitability and valuation. Despite impressive revenue growth, its high PE ratio indicates overvaluation, and it struggles with low margins and high debt levels. In contrast, companies like Cipla Ltd. and Dr. Reddy's Laboratories Ltd. exhibit strong profitability and more attractive valuations.

• • Bandaram Pharma has the highest revenue growth YoY at 81.93%, but is still unprofitable with low margins.
• • The company has the highest PE ratio of 274.21, indicating potential overvaluation.
• • Cipla and Dr. Reddy's lead in profitability metrics with solid ROE and ROCE.
• • Sun Pharma and Divi's Laboratories are financially strong with low debt levels and good margins.